Clopcare A 150mg/75mg Tablet
By Clopcare A
Rx
10 Tablet in a Strip

Composition
Aspirin(150mg) + Clopidogrel(75mg)

Manufacturer - Neocardiab care
303, Third Eye One, Opp Havmor, Panchvati, Ahmedabad 380006, INDIA

Expires on or after
January, 2028

liver
When using Clopcare A 150mg/75mg Tablet, it is important to exercise caution if you have liver disease. Your doctor may need to adjust the dosage accordingly. It is not advised to use Clopcare A 150mg/75mg Tablet in cases of severe liver disease. If you have a history of liver conditions, consult your doctor before taking Clopcare A 150mg/75mg Tablet to ensure proper guidance and dosage adjustments.

kidney
When using Clopcare A 150mg/75mg Tablet, caution is advised for patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Avoid in cases of severe kidney disease. Follow medical advice closely.

alcohol
It is advisable to avoid drinking alcohol while taking Clopcare A 150mg/75mg Tablet. Combining alcohol with this medication can increase the risk of stomach ulcer and gastric bleeding.

driving
Clopcare A 150mg/75mg Tablet may decrease alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms. Clopcare A 150mg/75mg Tablet does not impact driving ability.

pregnancy
Clopcare A 150mg/75mg Tablet is unsafe during pregnancy, as it poses a risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Clopcare A 150mg/75mg Tablet should be used with caution during breastfeeding as it may pass into breastmilk and potentially harm the baby. It is advisable to consult a healthcare provider before using this medication while breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹57
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024
